The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an update (Q81434774)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545253%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545253%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

A M Rovelli

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545253%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545253%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545253%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

41 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545253%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

S87-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545253%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2008.62

8 January 2020

exact match

0 references

cites work

Lysosomal storage disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Blood to brain to the rescue.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Hematopoietic cell transplantation activity in Europe for inherited metabolic diseases: open issues and future directions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Cord-blood transplants from unrelated donors in patients with Hurler's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Results of the Cord Blood Transplantation Study (COBLT): Outcomes of Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Patients with Lysosomal and Peroxisomal Storage Diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.62

7 January 2021